Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Clinical trial NCT01872260 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01872260
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-22
- Primary completion
- 2027-02-26
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.